Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for ...

Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab ...

Scientists have identified five specific blood proteins that can accurately predict a person's risk for developing a serious form of liver disease as early as 16 years before they experience symptoms, ...

Noninvasive spleen stiffness measurement improves risk prediction for liver-related complications in patients with ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...

Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital organ responsible for ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.

UChicago Medicine is using a new technology to destroy liver tumors without radiation, chemotherapy or even cutting the skin. Called histotripsy, it destroys tumors using sound waves.